Ethos price target raised to $27 from $21 at Citizens

Citizens analyst Matthew Carletti raised the firm’s price target on Ethos (LIFE) to $27 from $21 and keeps an Outperform rating on the shares. Ethos delivered mixed results with EPS below expectations but significantly stronger revenue, premium growth, and policy activation trends, supported by accelerating carrier partnerships, strong adoption of new insurance products, and expanding distribution opportunities that reinforce confidence in the company’s growth trajectory despite elevated marketing investment, the analyst tells investors in a research note.